Literature DB >> 6848810

Response of thiazide-induced hypokalemia to amiloride.

R F Maronde, M Milgrom, N D Vlachakis, L Chan.   

Abstract

The effects of amiloride hydrochloride on thiazide-induced hypokalemia were evaluated. In metabolic balance studies, amiloride reversed thiazide-induced urinary potassium loss, restored plasma bicarbonate concentration and pH to pretreatment levels, and produced further increases in aldosterone secretion. Effects of long-term administration of hydrochlorothiazide and an amiloride-hydrochlorothiazide combination were compared in outpatients who had experienced thiazide-induced hypokalemia while receiving oral potassium supplements. After eight weeks, those given hydrochlorothiazide alone had an average serum potassium level of 3.01 +/- 0.08 mEq/L). Those given the amiloride-hydrochlorothiazide combination had an average serum potassium level of 3.75 +/- 0.008 mEq/L, not significantly different from the control value (3.82 +/- 0.08 mEq/L). Both groups had increased plasma aldosterone concentrations and plasma renin activity. The potassium-conserving effect of amiloride persisted with extended therapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6848810

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  9 in total

1.  Update in new medications for primary care.

Authors:  Gerald W Smetana; Jane S Sillman
Journal:  J Gen Intern Med       Date:  2009-12-12       Impact factor: 5.128

Review 2.  Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy?

Authors:  D A Sica
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

Review 3.  Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats.

Authors:  Domenic A Sica
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Electrolyte disturbance with diuretics and ACEIs.

Authors:  Michael R Kolber; Scott Garrison; Ricky D Turgeon
Journal:  Can Fam Physician       Date:  2016-07       Impact factor: 3.275

5.  Sodium intake and multiple sclerosis activity and progression in BENEFIT.

Authors:  Kathryn C Fitzgerald; Kassandra L Munger; Hans-Peter Hartung; Mark S Freedman; Xavier Montalbán; Gilles Edan; Eva-Maria Wicklein; Ernst-Wilhelm Radue; Ludwig Kappos; Christoph Pohl; Alberto Ascherio
Journal:  Ann Neurol       Date:  2017-07       Impact factor: 10.422

6.  Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD: A Randomized Crossover Trial.

Authors:  Bart J Kramers; Iris W Koorevaar; Maatje D A van Gastel; Harry van Goor; Kenneth R Hallows; Hiddo L Heerspink; Hui Li; Wouter N Leonhard; Dorien J M Peters; Jiedong Qiu; Daan J Touw; Ron T Gansevoort; Esther Meijer
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-21       Impact factor: 8.237

Review 7.  Do non-potassium-sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? Recent evidence.

Authors:  A W Hoes; D E Grobbee; T M Peet; J Lubsen
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

8.  Network-based prediction of drug combinations.

Authors:  Feixiong Cheng; István A Kovács; Albert-László Barabási
Journal:  Nat Commun       Date:  2019-03-13       Impact factor: 14.919

Review 9.  Renal function monitoring in heart failure - what is the optimal frequency? A narrative review.

Authors:  Ahmed Al-Naher; David Wright; Mark Alexander John Devonald; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2017-10-22       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.